IP Library Granted Patent US 7,288,381
Granted Patent B2
US 7,288,381 · App. 10/027,725 · Granted Oct 30, 2007

Group 2 allergen specific IgE-Fabs and use thereof

Assignee: Phadia AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,288,381
App. No.
10/027,725
Granted
Oct 30, 2007
Kind
B2
Abstract

The present invention relates to group 2 allergen specific IgE-Fabs and whole Ig molecules as well as use thereof. More precisely, the present invention relates to grass pollen specific IgE-Fabs (Phl p2) and reagents, kits and vaccines comprising these. The invention also relates to use of group 2 specific IgE-Fabs and whole Ig for, inter alia, diagnosis, therapy and prevention of type I allergy.

Claims (19)

1. A grass pollen group 2 allergen specific human IgE Fab having a heavy chain consisting of the amino acid sequence as shown in SEQ ID NO: 7, SEQ ID NO: 8, or SEQ ID NO: 9, and a light chain consisting of the amino acid sequence as shown in SEQ ID NO: 10, SEQ ID NO: 11, or SEQ ID NO: 12.

2. A grass pollen group 2 allergen specific human IgE Fab having a heavy chain consisting of the amino acid sequence as shown in SEQ ID NO: 7, SEQ ID NO: 8, or SEQ ID NO: 9, and a light chain consisting of the amino acid sequence as shown in SEQ ID NO: 10, SEQ ID NO: 11, or SEQ ID NO: 12, respectively.

3. An isolated grass pollen group 2 allergen specific antibody comprising the variable regions of the IgE Fab of claim 2 grafted onto human IgG1.

4. A grass pollen group 2 allergen specific human IgE Fab having a heavy chain encoded by the nucleic acid sequence as shown in SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and a light chain encoded by the nucleic acid as shown in SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6, respectively.

5. The antibody according to claim 3 , wherein the antibody is directed against Phl p 2.

6. A diagnostic reagent comprising the antibody according to claim 3 .

7. A diagnostic kit comprising the reagent according to claim 6 .

8. The IgE Fab according to claim 2 , wherein the IgE Fab is directed against Phl p 2.

9. The IgE Fab according to claim 2 , wherein the IgE Fab is recombinantly produced.

10. A diagnostic reagent comprising the IgE Fab according to claim 2 .

11. A diagnostic kit comprising the reagent according to claim 10 .

12. A method for diagnosing type I allergy, comprising contacting a sample with the IgE Fab according to claim 2 .

13. A method for environmental allergen detection, comprising contacting a sample with the IgE Fab according to claim 2 .

14. A method for standardization of allergen extract, comprising standardizing the allergen extract with the IgE Fab according to claim 2 .

15. A grass pollen group 2 allergen specific human IgE Fab having a heavy chain encoded by the nucleic acid sequence as shown in SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and a light chain encoded by the nucleic acid as shown in SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6.

16. An isolated grass pollen group 2 allergen specific antibody comprising the variable regions of the IgE Fab of claim 4 grafted onto human IgG1.

17. The IgE Fab according to claim 4 , wherein the IgE Fab is directed against Phl p 2.

18. A diagnostic reagent comprising the IgE Fab according to claim 4 .

19. A diagnostic kit comprising the reagent according to claim 18 .

Assignments (2)
CHANGE OF NAME Recorded Oct 10, 2006
From: PHARMACIA DIAGNOSTICS AB
To: PHADIA AB
Reel/Frame 018375/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2002
From: FLICKER, SABINE; STEINBERGER, PETER; KRAFT, DIETRICH; VALENTA, RUDOLF
To: PHARAMACIA DIAGNOSTICS AB
Reel/Frame 012962/0441 →
Priority Claims (1)
SE 0004892 · Dec 29, 2000 · national
Continuity (1)
Related Publication 20030082659A1 · May 1, 2003